BIO Partners with Vending Machine for Token Design and Economic Simulations.
Announcing our partnership with BIO, a new financial layer for decentralised science. In this partnership we will provide token design, economic simulations and protocol parameterisations to BIO.
The Scope of our BIO Relationship
- Parameterising Genesis Auction 2: Parameterising the token allocation and asset weightings, optimising for protocol longevity and community galvanisation.
- Designing the BIO token system functionality: Designing how the BIO token integrates within the protocol, the userflow for interacting with the system, and it’s functionality across the entire decentralised science ecosystem.
- Supporting the economic framework for newly incubated bioDAOs: Designing baseline economic frameworks for each new bioDAO to simplify their initial economic design overhead, so the DAOs can focus on science.
- BIO economic simulations and parameterisations: Simulating the BIO protocol and optimising parameters for long-term success and sustainability.
Why BIO?
Bottom-up Funding, Strong Incentives, and Empowering Patients
Good health is one of the most precious resources, and when it is at risk, there is no greater call to action. But what options do you have when pharmaceutical solutions are lacking?
For many, this stalemate is a harsh reality: no cure, insufficient research, and a lack of funding. Thousands of niche online communities, like subreddits, unite over their shared suffering, constantly searching for solutions and willing to try experimental treatments in the hopes of finding a cure. These are highly motivated communities.
One of the many structural problems with Big Pharma today (which is a topic in itself) is how science is funded. The funding model is top-down, profit-driven, and often detached from patients and their actual needs. Funding dictates scientific research, research drives discovery, and discovery leads to cures. The question is: What options do these highly motivated patients have to influence the flow of funding and direct scientific research toward cures that impact their health? Until now, they had very few.
This is where BIO comes in.
Much like DeFi, which enables people in countries with capital controls to bypass traditional banking systems that have failed them, DeSci (Decentralised Science) offers a new way for patients to fund research that the conventional Big Pharma model has neglected. Motivated communities with niche health concerns can pool resources to directly fund research for cures.
BIO aims to bring this vision to life by simplifying the creation of bioDAOs for funding scientific research. At Vending Machine, our partnership with BIO focuses on eliminating the economic complexities for these communities and scientists, allowing them to focus on what truly matters — the science.
During this partnership, we will be sharing updates across these four critical tasks to bring the community with us on this journey to create a robust economic network that is ultimately geared towards accelerating scientific discovery and breakthrough medications.
We are thrilled to be working with BIO, stay updated by following both Vending Machine and BIO.
